Skip to content
Datasets/TARGET-NBL

Neuroblastoma

MixedMachine-extracted
TARGETAvailable from GDC

Can it answer your research question?

2 of 6 supported
  • Overall survival

    Supported

    Vital status and time are populated; median follow-up 6.2 years; 1,116 cases with follow-up; endpoint: overall survival.API

  • Progression or recurrence

    Not supported

    progression_or_recurrence is informative for no case in the harmonized records.API

  • Treatment response

    Not supported

    treatment_outcome is populated for no case in the harmonized records.API

  • Which drug was given

    Not supported

    therapeutic_agents is recorded for no case in the harmonized records.API

  • Stage-adjusted modelling

    Not supported

    ajcc_pathologic_stage is informative for no case in the harmonized records.API

  • Analysis by race or ethnicity

    Supported

    Ethnicity is informative for 90% of cases.API

Judged from the repository’s own field completeness (thresholds). “Not measured” means we have not probed that field for this record, not that the data lack it.

At a glance

Every percentage is the repository’s own record of what is filled in
CasesAPI
1,132
Measurement types
7
13,525 files, 21 TB
Follow-upAPI
6.2 years
for 1,116 of 1,132 cases; overall survival
Treatment responseAPI
Not recorded

SubjectCALC

Peripheral nervous system

As filed by the repository

Not ApplicableNeuroepitheliomatous NeoplasmsOther endocrine glands and related structuresStomachMeningesSkinUnknownBones, joints and articular cartilage of limbsConnective, subcutaneous and other soft tissuesLymph nodesHematopoietic and reticuloendothelial systemsRenal pelvis

Who is in the cohortAPI

A usable value“Not reported” or “unknown”No value recorded
  • Sex638 male · 482 female · 12 no value recorded
  • Race824 white · 133 black or african american · 30 asian · 14 2 other · 119 unknown · 12 no value recorded
  • Ethnicity897 not hispanic or latino · 118 hispanic or latino · 105 unknown · 12 no value recorded
  • Vital status668 alive · 448 dead · 4 unknown · 12 no value recorded

Age at diagnosis

Median 3, middle half 1–4, range 0–21 years across 1,120 cases.

What was measured, and on how many

7 measurement types, none covering the whole cohort.

  • Bulk RNA sequencing155 of 1,132 · 14%
  • Whole genome sequencing143 of 1,132 · 13%
  • Whole exome sequencing222 of 1,132 · 20%
  • Targeted DNA panel sequencing499 of 1,132 · 44%
  • DNA methylation array225 of 1,132 · 20%
  • Clinical842 of 1,132 · 74%
  • Structural Variation155 of 1,132 · 14%
Platform, files and data levels
AssayPlatformFilesLevels
Bulk RNA sequencingAPIillumina1,458-
Whole genome sequencingAPIillumina173-
Whole exome sequencingAPIillumina3,522-
Targeted DNA panel sequencingAPIillumina7,662-
DNA methylation arrayAPIillumina705-
ClinicalAPI-3-
Structural VariationAPI-648-
How complete all 29 clinical fields are - 7 informative for at least 80% of cases

A field counts as informative only when it holds a real value. “Not reported” blocks an analysis just as a missing field does. Fields marked 1:n can hold several records per case, so they show the share of cases with any record.

Informative - a usable valuePresent but uninformative - “not reported” or “unknown”Absent - no value recorded

Outcome

  • Vital statusAPI99%
  • Cause of deathAPI0%
  • Progression or recurrenceAPI0%
  • Last known disease statusAPI0%

Follow-up

  • Disease response at follow-upAPI0%
  • Progression at follow-upAPI0%
  • ECOG performance statusAPI0%

Treatment

  • Treatment givenAPI74%
  • Prior treatmentAPI0%
  • Treatment typeAPI0%
  • Therapeutic agentsAPI0%
  • Treatment outcomeAPI0%
  • Regimen or line of therapyAPI0%

Staging

  • AJCC pathologic stageAPI0%
  • AJCC clinical stageAPI0%

Diagnosis

  • Primary diagnosisAPI99%
  • Tissue or organ of originAPI87%
  • Prior malignancyAPI0%
  • Synchronous malignancyAPI0%

Pathology

  • Morphology (ICD-O)API99%
  • Classification of tumorAPI74%
  • Tumor gradeAPI0%

Demographics

  • Sex at birthAPI99%
  • EthnicityAPI90%
  • RaceAPI88%
  • Population groupAPI0%
  • Country of residenceAPI0%

Exposure

  • Tobacco smoking statusAPI0%
  • Alcohol historyAPI0%

Access

MixedSome components are open; others need approval.

Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required

Open components
1,568 open-access files
Controlled components
11,957 controlled-access files
Typical turnaround
days to a few weeks after signing official approval
License
NIH Genomic Data Sharing Policy terms
Citation requirement
Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.

What it is good for

Written and checked by a reviewer, not generated from metadata.

No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.

What it cannot tell you

Written by a reviewer against the source, not inferred from what is missing.

No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.

Who has used it

Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.

Analyzed the dataCALC2
49
accession in the methods; 89% of a 28-article sample really cited it
Declared using it
13
named in a data availability statement
Cited the paper
989
attention to the publication, not reuse of the data
Against expectation
Well below
about 458 articles expected; index -3.20

What articles did with it

Only the last row counts as reuse. Where the accession appears in an article tells us what the authors did with the data.

  • Cited the paper989
  • Mentioned the dataset6
  • Accession found in text30
  • Declared using it13
  • Analyzed the data49

Against comparable datasets

49 articles analyzed these data. About 458 would be expected. The expectation comes from a model of size, age, breadth and access tier.

  • Analyzed it49
  • Expected~458
Well known, little used
The publication has 989 citations, about 20 for every article that analyzed the data. The finding travelled further than the resource did.
How this count was corrected
Europe PMC returned 55 articles for METHODS:"TARGET-NBL", but it indexes the hyphen in TARGET-NBL as a word break, so that query also matches the two words in ordinary prose. Of 28 sampled articles whose full text we could read, 25 contained the literal accession (73-96%, 95% interval). The published figure is the raw count scaled by that fraction.
Reuse assessment
  • 49 article(s) reference this dataset's accession in a methods section, fewer than the 458.4 predicted for comparable datasets (index -3.20). It is not flagged as underexplored because more than 25 articles have already analysed it, which is not the position a researcher looking for neglected data is looking for.

Compared against 132 datasets in this corpus with a citable accession and sufficient metadata. See Methods for the model.

Original publication

Articles that analyzed the data

Examples, not the full list. 109 articles matching this dataset's accession search were retrieved and graded individually; these are the strongest of those.

Deep-review sample: author overlap and funding were checked only for the 10 articles listed here, not for every article examined. Of the 10 that analyzed the data, 8 of the 10 we could check had no author in common with the generating team, and 8 of the 10 we could check were themselves NCI-funded. These are sample counts, not population estimates.

Community examples

Share your example

Analyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.

Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.

Start here

Starter code generated from this record’s own identifiers, then the access steps.

Get the data in code

GDC: list open files and download thempython

Open-access files need no account. Controlled files need an approved dbGaP request and a token passed to gdc-client.

import json, requests

PROJECT = "TARGET-NBL"
filters = {"op": "and", "content": [
    {"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
    {"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
          "fields": "file_id,file_name,data_category,data_type,file_size",
          "size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")

# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
    fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txt
GDC: clinical table for every casepython
import json, requests

filters = {"op": "in", "content": {"field": "project.project_id", "value": ["TARGET-NBL"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
          "fields": ",".join([
              "submitter_id", "demographic.vital_status", "demographic.days_to_death",
              "diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
              "diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("TARGET-NBL_clinical.tsv", "w").write(tsv)
This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-target-nbl.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
    print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'

Access steps

  1. 1
    Open the project in the GDC Data PortalFor people5 minutes

    Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.

    https://portal.gdc.cancer.gov/projects/TARGET-NBL

    Generated from repository policy. Check the linked policy before downloading.

  2. 2
    Download the open files without an accountFor peopleminutes to hours, by cohort size

    1,568 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.

    gdc-client download -m gdc_manifest.txt
    https://gdc.cancer.gov/access-data/gdc-data-transfer-tool

    Generated from repository policy. Check the linked policy before downloading.

  3. 3
    Request controlled access through dbGaPFor peopledays to a few weeks after signing official approval

    11,957 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs000467.

    Requires: eRA Commons account, institutional signing official approval, dbGaP data access request for phs000467

    https://gdc.cancer.gov/access-data/obtaining-access-controlled-data

    Generated from repository policy. Check the linked policy before downloading.

  4. 4
    Download controlled files with your tokenFor people

    An approved request yields a token. The same manifest fetches nothing controlled without it.

    Requires: approved dbGaP request, GDC authentication token

    gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt
    https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000467

    Generated from repository policy. Check the linked policy before downloading.

  5. 5
    Query the project from code, with no credentialsFor agents

    The file index is public even where files are not, so an agent can size the cohort before anyone requests access.

    curl -s 'https://api.gdc.cancer.gov/files' --get \
      --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["TARGET-NBL"]}}' \
      --data-urlencode 'fields=file_id,file_name,data_type' \
      --data-urlencode 'size=10000' --data-urlencode 'format=TSV'
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

  6. 6
    Pass the token when the agent needs controlled filesFor agents

    Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.

    Requires: GDC authentication token

    curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
    https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/

    Generated from repository policy. Check the linked policy before downloading.

Provenance

All of it, and more, is in this record’s JSON.

Identifiers

Versions and verification

Released
1 Jan 2004
Metadata retrieved
18 Sept 2026
Review status
Machine-extracted
Data generation funding
Funded data generation

Funding

Awards resolved through NIH RePORTER. Awards that paid to generate these data are listed apart from awards that paid to reuse them. Both are returns on NCI investment, but different ones.

Funded data generation

  • U10CA098543Children's Oncology Group Chair's GrantPETER C. ADAMSON, GREGORY H REAMANFY2003-2013API2
  • R01CA124709The Genetic Basis of Neuroblastoma TumorigenesisJOHN M MARISFY2008-2017API2
  • U10CA098413Children's Oncology Group Statistics and Data Center GrantJAMES R ANDERSON, Meenakshi DevidasFY2003-2013API
  • R01CA060104Clinical Correlative Studies of NeuroblastomaROBERT Charles SEEGERFY1998-2010API

Funded reuse of these data

  • R35CA210064Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in CancerA. THOMAS LOOKFY2016-2022API
  • R01CA180692Role of LMO1 in Neuroblastoma Initiation and MaintenanceA. THOMAS LOOK, JOHN M MARISFY2015-2019API
  • R01CA196631A network platform to connect drug response and prognosis phenotypes for cancersHu LiFY2016-2018API
  • R01CA104125Cytoskeletal Dynamics in Pancreatic Cancer MetastasisMARK A. MC NIVEN, Gina Lynn RazidloFY2004-2019API
  • R00CA178189Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk NeuroblastomaShizhen ZhuFY2015-2017API
  • K08CA215105Precision Medicine by Targeting Cell Adhesion in MelanomaAlexander MevesFY2017-2021API
  • R01CA204974Structural Variation in NeuroblastomaSharon DiskinFY2016-2020API
  • R01CA237170Characterization of high-grade serous ovarian cancer subtypes via single-cell profilingJennifer Anne Doherty, Casey S GreeneFY2019-2024API
  • R01CA236890Linking nucleotide and amino acid metabolism to cholesterol synthesis by MYCNHAN-FEI DINGFY2020-2024API

Funded infrastructure or harmonization

  • P30CA021765Cancer Biology (CBP)Douglas R. Green, Elizabeth FoxFY1985-2026API
  • P50CA211024Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate CancerHimisha Beltran, David S. RickmanFY2017-2021API
  • P30CA008748Antitumor AssessmentElisa de Stanchina, FRANCESCA M GANYFY1985-2026API
  • P50CA217694Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial SarcomaMarc Ladanyi, SAMUEL SINGERFY2018-2025API

For softwarerecord JSON